Neuren Pharmaceuticals Expands Market Presence
Company Announcements

Neuren Pharmaceuticals Expands Market Presence

Neuren Pharmaceuticals Limited (AU:NEU) has released an update.

Neuren Pharmaceuticals Limited has announced the application for quotation of 120,000 new fully paid ordinary securities under the ASX code ‘NEU’, dated Monday, June 17, 2024. This move signifies the company’s latest financial development aimed at potential investors and market watchers.

For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskNeuren Pharmaceuticals Reports Strong Q3 Financial Growth
TipRanks Australian Auto-Generated NewsdeskNeuren Pharmaceuticals Gains from Voucher Sale
TipRanks Australian Auto-Generated NewsdeskNeuren Pharmaceuticals Updates Policy Amid Financial Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App